Sell-Off Alert: HEXO (TSX:HEXO) Stock Is Down After CFO Quits

HEXO Corp. (TSX:HEXO)(NYSE:HEXO) stock is falling after a key management change. Should you buy a key competitor instead?

| More on:

This summer, pundits were asking themselves whether the share price of pot stock HEXO (TSX:HEXO)(NYSE:HEXO) was justified according to its fundamentals — a question not reserved just for HEXO.

Then HEXO’s chief brand officer and co-founder Adam Miron stepped down in July. The stock plunged, losing a fifth of its value.

Then on Friday, HEXO’s chief financial officer Michael Monahan threw in the towel. At close of play, the stock was down by a quarter of a percent, though this deepened quickly to a 4.2% loss by Friday evening in after-hours trading. Today has already seen the stock lose 6% at the time of writing.

Since Monahan only took the reins as CFO in June, investors may begin treating HEXO to a higher level of scrutiny, especially because it’s been such a short period of time since its previous management shake-up. However, Monahan cited personal reasons for standing down, and HEXO’s CEO and co-founder, Sebastien St-Louis, has praised his contribution to the business.

Cannabis bullishness prevails, but it’s a stock-picker’s market

This is one sector that doesn’t play nice with ETFs. While businesses in other sectors tend to move as one flock, such as banking or precious metals, cannabis is still too nebulous an industry for that. With companies pursuing a wide range of disparate corporate strategies, from deals with seemingly unrelated partners to business plans that depend on untried markets, the sector has yet to stabilize.

Already having ditched more than half its value from a year-long high of $11.29, HEXO could be looking at an even deeper sell-off after a change of staff that comes amid ratcheting uncertainty in the markets. Additionally, there’s always the possibility that HEXO could even become one of the first fairly large cannabis companies to be bought out entirely by a larger competitor.

Consider swapping out shares for this CBD market leader

In the meantime, cannabis investors looking to jump ship might want to reinvest in companies with more upside such as Charlotte’s Web Holdings. From high growth potential to a well-developed sense of branding, Charlotte’s Web is a stronger play than many other stocks in this space. Its operational space has grown by almost 300% since last year, with revenue leaping by 45%.

If you’re looking to jump on the CBD train, Charlotte’s Web is a good place to join. While some areas of the U.S. still look unfavourably upon hemp-based products, hemp growing became legal in the U.S. in December. This, along with a key deal with grocery giant Kroger, makes Charlotte’s Web an early industry leader in the CBD sector and a strong play for assured growth in a tried-and-tested market.

The bottom line

Companies with tried-and-tested business models, especially the ones most likely to become profitable ahead of the pack, are the best investments in this space. While HEXO may recover some of its losses, losing a high-ranking member of management is not usually a good sign. Charlotte’s Web remains a strong play, meanwhile, as the market is increasingly bullish on CBD growth, especially in the U.S.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned. The Motley Fool owns shares of Charlotte's Web Holdings.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »